货号 |
纯度 |
规格 |
货期 |
|
C22975-250mg |
98% |
250mg |
一周 |
|
C22975-100mg |
98% |
100mg |
一周 |
|
C22975-1g |
98% |
1g |
一周 |
|
C22975-500mg |
98% |
500mg |
一周 |
|
C22975-5g |
98% |
5g |
一周 |
|
|
|
|
|
|
CAS |
33419-42-0 |
|
|
|
名称 |
Etoposide |
|
|
|
英文名称 |
Etoposide |
|
|
|
分子式 |
C29H32O13 |
|
|
|
分子量 |
588.56 |
|
|
|
溶解性 |
SolubleinDMSO(30mg/ml),dimethylformamide,ethylether,chloroform:methanol(1:1),methanol(slightly),acetone(slightly),water(<1mg/ml)at25°C,andethanol(<1mg/ml)at25°C |
熔点 |
251°C |
|
|
|
溶解性 |
SolubleinDMSO(30mg/ml),dimethylformamide,ethylether,chloroform:methanol(1:1),methanol(slightly),acetone(slightly),water(<1mg/ml)at25°C,andethanol(<1mg/ml)at25°C |
产品介绍 |
依托泊苷是一种抗肿瘤剂,它与拓扑异构酶Ⅱ及DNA结合成复合物,以增强双链和单链DNA的裂解,并可逆地抑制再连接。在细胞周期S期和G2期阻断细胞周期,在正常和肿瘤细胞系中诱导细胞凋亡,抑制癌蛋白Mdm2的合成,在过渡表达Mdm2的肿瘤细胞系中诱发细胞凋亡。 |
别名 |
4'-去甲表鬼臼9-(4,6-O-亚乙基-β-e-吡喃葡萄糖苷)VP-16-213;依托泊苷;4'-Demethylepipodophyllotoxin9-(4,6-O-Ethylidene-β-D-glucopyranoside) |
应用 |
InhibitsDNAsynthesisviatopoisomeraseIIinhibition |
信号词 |
Danger |
|
|
|
风险声明(欧洲) |
R45;R22 |
|
|
|
安全声明(欧洲) |
S53;S45 |
|
|
|
警示性声明 |
P201,P308+P313 |
|
|
|
危害码(欧洲) |
T |
|
|
|
个人防护设备 |
Eyeshields,full-faceparticlerespiratortypeN100(US),Gloves,respiratorcartridgetypeN100(US),typeP1(EN143)respiratorfilter,typeP3(EN143)respiratorcartridges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|